IDENTIFICATION OF T-CELL AND B-CELL EPITOPES RECOGNIZED BY HUMANS IN THE C-TERMINAL 42-KDA DOMAIN OF THE PLASMODIUM-FALCIPARUM MEROZOITE SURFACE PROTEIN (MSP)-1
V. Udhayakumar et al., IDENTIFICATION OF T-CELL AND B-CELL EPITOPES RECOGNIZED BY HUMANS IN THE C-TERMINAL 42-KDA DOMAIN OF THE PLASMODIUM-FALCIPARUM MEROZOITE SURFACE PROTEIN (MSP)-1, The Journal of immunology, 154(11), 1995, pp. 6022-6030
The 42-kDa, C-terminal region of the merozoite surface protein-1 (MSP-
1) of Plasmodium falciparum is a putative malaria vaccine candidate Ag
. Nine synthetic peptides corresponding to predicted T cell sites of M
SP-1 in blocks 15 and 16 and eight overlapping peptides representing t
he conserved block 17 were used to identify naturally immunogenic epit
opes. These peptides were tested for their ability to induce prolifera
tion of PBMC from residents in western Kenya, where malaria transmissi
on is holoendemic. Six peptides (PL145, PL146, PL147, PL148, PL149, an
d PL150) from blocks 15 and 16 induced a positive proliferative respon
se in >30% of the individuals tested, and three peptides (PL151, PL152
, and PL153) induced a proliferative response in <25% of the donors. A
mong these peptides, PL146 was from the highly conserved region, PL150
was from a polymorphic region, and all other peptides were from a dim
orphic region of blocks 15 and 16. In block 17, only three peptides, P
L99, PL100, and PL103, induced proliferation in 30 to 37% of the volun
teers. The rest of the peptides induced a proliferative response in ap
proximately 13 to 25% of the donors. The plasma from these donors wide
ly reacted with different allelic forms of 19-kDa recombinant proteins
representing block 17 and recognized at least two linear B epitopes,
PL104 and PL97. In summary, this study revealed that a majority of imm
unodominant T and B epitopes are localized in the conserved or dimorph
ic regions that are nonpolymorphic in the 42-kDa protein of MSP-1. Thi
s study suggests that incorporation of T epitopes from the dimorphic b
locks 15 and 16 in a vaccine construct may be useful to ensure Ag-spec
ific memory responses.